1800-272-662
Shopping Cart 0
countryflagAU
Login

Ardent Health Partners, Inc.

Healthcare US ARDT

8.97USD
-0.07(0.77%)

Last update at 2026-03-11T14:54:00Z

Day Range

8.859.09
LowHigh

52 Week Range

11.3120.72
LowHigh

Fundamentals

  • Previous Close 9.04
  • Market Cap2204.22M
  • Volume23780
  • P/E Ratio9.17
  • Dividend Yield-%
  • EBITDA544.17M
  • Revenue TTM6024.26M
  • Revenue Per Share TTM44.32
  • Gross Profit TTM 3453.36M
  • Diluted EPS TTM1.68

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2018-12-31
Income before tax 363.06M 151.61M 311.48M 295.89M -114.61600M
Minority interest -89.36500M -72.65300M -76.46200M -90.31800M -
Net income 210.34M 50.29M 188.91M 154.26M -143.02400M
Selling general administrative 1097.12M 3607.66M 3371.68M 3132.33M 2677.70M
Selling and marketing expenses - 14.87M 956.26M 906.98M -
Gross profit 3431.32M 4416.08M 4174.52M 3943.07M 4161.88M
Reconciled depreciation 146.29M 140.84M 138.17M 137.20M -
Ebit 409.63M 209.15M 393.53M 389.72M 102.56M
Ebitda 555.92M 350.00M 531.70M 526.92M 245.75M
Depreciation and amortization 146.29M 140.84M 138.17M 137.20M 143.19M
Non operating income net other - - - - -
Operating income 405.76M 229.50M 802.84M 322.72M 149.76M
Other operating expenses 5603.01M 5179.98M 5867.83M 5361.16M 4023.23M
Interest expense 65.58M 65.42M 82.05M 93.83M 108.59M
Tax provision 63.35M 20.78M 46.11M 51.31M -
Interest income - - - - -
Net interest income -65.57800M -65.42500M -82.05200M -93.83400M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 63.35M 22.64M 46.11M 51.31M -11.29100M
Total revenue 5966.07M 5409.48M 5129.69M 4870.40M 4161.88M
Total operating expenses 3068.26M 5200.04M 4912.66M 4410.47M 4075.77M
Cost of revenue 2534.76M 993.40M 955.17M 927.33M -
Total other income expense net -42.70200M -77.89000M -491.36100M -26.83400M -264.37300M
Discontinued operations - - - - -
Net income from continuing ops 299.71M 122.94M 265.37M 244.58M -
Net income applicable to common shares - - - - -
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2018-12-31
Total assets 4956.10M 4731.56M 4859.88M - 2746.27M
Intangible assets 76.93M 76.93M 76.93M - -
Earning assets - - - - -
Other current assets 417.84M 299.57M 234.01M - 186.83M
Total liab 3433.74M 3649.24M 3809.57M - 2034.43M
Total stockholder equity 1521.20M 670.90M 639.05M - 331.64M
Deferred long term liab - - - - -
Other current liab 519.74M 422.49M 387.48M - 385.52M
Common stock 1.43M 496.88M 510.97M - 504.69M
Capital stock - - - - -
Retained earnings 365.80M 155.45M 101.55M - -167.16000M
Other liab - - - - -
Good will 852.08M 844.70M 844.70M - 822.03M
Other assets - -371.20900M - - 0.00000M
Cash 556.78M 437.58M 456.12M - 59.66M
Cash and equivalents - - - - -
Total current liabilities 945.42M 994.10M 808.60M - 624.83M
Current deferred revenue - 18.02M 17.35M - -
Net debt 1725.40M 1959.04M 1932.23M - 1201.19M
Short term debt 55.62M 61.03M 65.63M - 8.96M
Short long term debt 9.23M 18.61M 16.09M - -
Short long term debt total 2282.19M 2396.62M 2388.35M - 1260.86M
Other stockholder equity 1144.24M -174.01400M - - -
Property plant equipment - - - - -
Total current assets 1832.75M 1618.09M 1409.25M - 860.42M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments - 8.70M 21.40M - -
Net receivables 743.03M 775.45M 611.96M - 529.12M
Long term debt 1085.82M 1168.25M 1161.90M - -
Inventory 115.09M 105.48M 107.15M - 84.81M
Accounts payable 401.25M 474.54M 320.80M - 230.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 9.74M 18.56M 26.53M - -5.88800M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 142.97M 138.01M 93.98M - 50.11M
Deferred long term asset charges - - - - -
Non current assets total 3123.35M 3113.47M 3450.62M - 1885.85M
Capital lease obligations 1187.14M 1209.76M 1210.37M - -
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2018-12-31
Investments -220.46000M -137.98300M 46.58M -136.25900M -
Change to liabilities - - - - -
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities 24.64M -102.26200M -270.33100M -283.90700M 353.22M
Change to operating activities - - - - -
Net income 299.71M 53.90M 188.91M 154.26M -143.02400M
Change in cash 119.21M -18.54700M -262.11200M 658.57M -12.29800M
Begin period cash flow 437.58M 456.12M 718.24M 59.66M 71.96M
End period cash flow 556.78M 437.58M 456.12M 718.24M 59.66M
Total cash from operating activities 315.03M 221.70M -38.35900M 146.91M 159.59M
Issuance of capital stock 208.66M 0.00000M 0.00000M - -
Depreciation 146.29M 140.84M 138.17M 137.20M 143.19M
Other cashflows from investing activities -1.70700M -0.57500M -8.68600M 1.47M 28.35M
Dividends paid 0.00000M 0.00000M 174.81M 62.13M -
Change to inventory -9.40700M 1.67M 4.67M -5.73100M -1.02900M
Change to account receivables 40.00M -181.09900M -17.18400M -96.46500M -9.04800M
Sale purchase of stock - - - - -
Other cashflows from financing activities -67.25900M -95.23600M -79.11100M -137.33200M 1.47M
Change to netincome - - - - -
Capital expenditures 187.51M 137.41M 151.11M 139.00M 160.66M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -181.75100M -56.31100M -325.65400M -261.12500M 14.54M
Stock based compensation 17.98M 0.90M 0.61M 0.55M -
Other non cash items 8.76M 78.36M -86.51300M 146.67M 152.70M
Free cash flow 127.52M 84.29M -189.46600M 7.91M -1.07100M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ARDT
Ardent Health Partners, Inc.		 -0.07 0.77% 8.97 9.17 8.20 0.37 1.88 0.66 6.77
HCA
HCA Holdings Inc		 0.51 0.09% 538.15 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 - -% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Ardent Health Partners, Inc.

340 Seven Springs Way, Brentwood, TN, United States, 37027

Key Executives

Name Title Year Born
Mr. Martin J. Bonick FACHE, M.H.A. President, CEO & Director 1973
Mr. Alfred Lumsdaine CPA Chief Financial Officer 1965
Mr. Stephen Christopher Petrovich Executive VP, General Counsel, Chief Legal Officer & Secretary 1967
Mr. David W. Schultz President of Hospital Operations 1971
Jess Botros Vice President of IT Strategy & Operations NA
Mr. David Byers CPA Senior VP & Chief Accounting Officer 1981
Mr. Lonnie Garrison PMP Chief Technology Officer NA
Ms. Anika Gardenhire B.S.N., R.N. Chief Digital & Information Officer 1983
Mr. David Anthony Styblo C.F.A. Senior Vice President of Investor Relations NA
Mr. Jason Ehrlinspiel Chief Compliance Officer 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.